Fmoc-S-p-methoxybenzyl-L-cysteine is an Fmoc-protected, sulfur-substituted L-cysteine derivative in which the thiol side chain is alkylated with a p-methoxybenzyl (PMB) group, yielding a protected thioether functionality alongside the amino acid backbone. The molecule contains a free carboxylic acid and an Fmoc-protected α-amino group, with the side chain bearing a thioether (S-CH2-aryl) rather than a free thiol, and the L stereochemistry is specified by the product name. In peptide synthesis workflows, it functions as a protected cysteine building block that supports controlled chemoselectivity by masking both the α-amino functionality (via Fmoc) and the cysteine sulfur (via PMB) while enabling stepwise assembly of cysteine-containing peptide sequences on a solid support or in protected intermediate strategies.
Fmoc-S-p-methoxybenzyl-L-cysteine is an Fmoc-protected L-cysteine derivative in which the thiol side chain is masked as an S-p-methoxybenzyl thioether while the α-amino group is protected by the fluorenylmethoxycarbonyl (Fmoc) group. The molecule therefore presents an Fmoc carbamate for base-labile N-deprotection during solid-phase or solution peptide synthesis, along with a chiral α-center typical of cysteine stereochemistry. The p-methoxybenzyl (PMB) thioether functions as a stable sulfur protecting strategy that can be selectively removed under oxidative or electrophilic conditions to regenerate a cysteine-equivalent thiol for subsequent coupling, ligation, or functionalization. The aromatic PMB substituent and the Fmoc fluorene scaffold contribute to controlled hydrophobicity and strong chromatographic behavior, supporting its use as a defined chiral amino acid building block and intermediate for sulfur chemistry in peptide and medicinal chemistry workflows.
1. Peptide Synthesis
Fmoc-S-p-methoxybenzyl-L-cysteine is used in peptide building block preparation where Fmoc-protected amino functionality supports standard peptide coupling chemistry after Fmoc deprotection. The α-amino group protected as an Fmoc carbamate and the side-chain sulfur protected as a PMB thioether allow incorporation of cysteine residues into peptide chains while minimizing premature thiol reactivity during chain assembly. The masked thiol can be unveiled at a later stage to enable disulfide formation, thioether/thiol-based conjugation, or side-chain functional group transformations without disturbing earlier peptide bonds. Downstream peptide analogs prepared from this chiral cysteine derivative are suitable for generating defined cysteine-containing sequences for structure-activity relationship studies and chemical biology probes, while maintaining compatibility with protecting-group orthogonality strategies.
2. Bioconjugation Chemistry
Fmoc-S-p-methoxybenzyl-L-cysteine serves as a cysteine-equivalent intermediate for bioconjugation workflows that rely on controlled thiol availability and chemoselective attachment. The PMB-masked sulfur reduces nonspecific reactivity during synthesis of peptide tags, linkers, or sensing motifs, while the Fmoc group enables sequential deprotection steps to control when the thiol functionality becomes available for conjugation. Thiol regeneration from the protected sulfur can be applied to form disulfide-linked conjugates, install thioether linkages via alkylation, or support maleimide-type coupling strategies when thiol is presented in a controlled manner. Resulting cysteine-bearing conjugates can be used to label peptides, proteins, or biomolecular assemblies in analytical and biochemical research contexts where defined sulfur chemistry and stereochemical integrity matter.
3. Peptidomimetics And SAR
Fmoc-S-p-methoxybenzyl-L-cysteine is applicable to peptidomimetic and medicinal chemistry programs that require cysteine side-chain incorporation with predictable reactivity control. The protected thiol and Fmoc-protected amino group enable the synthesis of cysteine-containing fragments, cyclic or constrained motifs, and sulfur-functionalized analogs used in structure-activity relationship studies. The PMB thioether can be converted to a reactive thiol handle at a chosen stage, supporting selective formation of thioether bridges, disulfide constraints, or downstream sulfur-based derivatization that modulates conformation and binding-site interactions. The resulting sulfur-bearing analogs function as defined chiral intermediates for fragment expansion, molecular design iterations, and SAR library construction in applied drug discovery chemistry.
4. Process Chemistry Intermediate
Fmoc-S-p-methoxybenzyl-L-cysteine is suitable for process chemistry intermediate preparation where orthogonal protection of nitrogen and sulfur supports scalable, stepwise manufacturing routes. The Fmoc carbamate provides a base-labile handle for controlled N-deprotection, while the PMB thioether offers a sulfur-protection mode that can tolerate peptide-coupling conditions and common purification steps. The presence of two aromatic protecting groups, Fmoc and PMB, can facilitate robust solid-state handling and chromatographic separation during intermediate isolation, contributing to reproducible downstream conversion to cysteine-functional products. Industrially relevant use cases include fine chemical synthesis of protected cysteine building blocks, preparation of cysteine-containing linker systems, and manufacturing of defined sulfur-functional intermediates for specialty chemical production and peptide-based ingredient development.
5. Side-Chain Functionalization
Fmoc-S-p-methoxybenzyl-L-cysteine enables side-chain functionalization strategies that exploit the cysteine sulfur chemistry while preserving peptide integrity during upstream synthesis. The PMB-protected sulfur can be unmasked to generate a thiol-equivalent nucleophile that participates in thioether formation, disulfide exchange, or selective attachment to electrophilic reagents used in linker and scaffold construction. The Fmoc group supports controlled timing of N-deprotection, allowing the compound to serve as a building block for generating cysteine-bearing intermediates that can be further elaborated into cyclic thioether motifs, redox-active disulfide-containing structures, or sulfur-substituted analogs. The resulting functionalized derivatives can be employed in chemical biology research intermediate generation, analytical standard development for sulfur-containing species, and synthetic methodology studies focused on stereodefined amino acid derivatization and downstream sulfur functional group transformations.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More